GlassScriptPhysician profile
Edward Francis Dunne
NPI 1215000575
$2,377.16
in general payments reported to CMS, 2019-2025
29 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $198 · 2021: $609 · 2022: $228 · 2023: $198 · 2024: $202 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $629.92 | 2019-2024 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $426.98 | 2023-2025 | Gemtesa |
| Urovant Sciences INC | $177.43 | 2021-2022 | |
| Myovant Sciences INC. | $130.22 | 2021-2022 | |
| Tolmar, INC. | $106.80 | 2024-2025 | Jatenzo, Eligard |
| Ferring Pharmaceuticals INC. | $89.57 | 2019 | |
| Procept Biorobotics Corporation | $75.37 | 2023-2025 | Aquabeam Robotic System |
| Antares Pharma, INC. | $67.60 | 2019-2024 | Xyosted |
| Boston Scientific Corporation | $62.73 | 2019-2020 | |
| Pfizer INC. | $47.17 | 2019-2025 | |
| Mission Pharmacal Company | $46.96 | 2019 | |
| Metuchen Pharmaceuticals | $45.29 | 2019-2020 | |
| Acerus Pharmaceuticals Corporation | $43.17 | 2021 | |
| Endo Pharmaceuticals INC. | $41.88 | 2019 | |
| Axonics, INC. | $41.47 | 2024 | Axonics |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $40.77 | 2021 | |
| Olympus America INC. | $39.93 | 2021 | |
| Dendreon Pharmaceuticals LLC | $36.14 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $32.99 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.99 | 2022 | |
| Urogen Pharma, INC. | $24.57 | 2021 | |
| Immunitybio, INC. | $23.89 | 2025 | |
| Photocure INC | $22.99 | 2020 | |
| Corcept Therapeutics | $18.54 | 2019 | |
| Neotract INC. | $17.65 | 2019 | |
| Foundation Medicine, INC. | $17.10 | 2020 | |
| Laborie Medical Technologies Corp. | $16.39 | 2021 | |
| Accord Healthcare, INC. | $14.74 | 2022 | |
| Myriad Genetic Laboratories, INC. | $12.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Dunne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.